Novocure Ltd. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
10,359.00
15,490.00
33,087.00
82,888.00
177,026.00
248,069
Cost of Goods Sold (COGS) incl. D&A
7,013.00
10,036.00
20,574.00
39,870.00
55,609.00
82,583
Gross Income
3,346.00
5,454.00
12,513.00
43,018.00
121,417.00
165,486
SG&A Expense
67,805.00
85,610.00
116,473.00
151,923.00
160,745.00
199,158
EBIT
64,459.00
80,156.00
103,960.00
108,905.00
39,328.00
33,672
Unusual Expense
-
-
36.00
6,412.00
-
-
Non Operating Income/Expense
157.00
104.00
356.00
396.00
549.00
-
Interest Expense
12,668.00
183.00
2,879.00
6,922.00
11,693.00
16,908
Pretax Income
77,017.00
80,300.00
107,147.00
121,464.00
48,497.00
45,942
Income Tax
353.00
382.00
4,434.00
10,381.00
13,165.00
17,617
Consolidated Net Income
77,370.00
80,682.00
111,581.00
131,845.00
61,662.00
63,559
Net Income
77,370.00
80,682.00
111,581.00
131,845.00
61,662.00
63,559
Net Income After Extraordinaries
77,370.00
80,682.00
111,581.00
131,845.00
61,662.00
63,559
Net Income Available to Common
77,370.00
80,682.00
111,581.00
131,845.00
61,662.00
63,559
EPS (Basic)
6.09
6.35
3.67
1.54
0.70
0.69
Basic Shares Outstanding
12,713.50
12,713.50
30,401.60
85,558.40
88,546.70
91,828
EPS (Diluted)
6.09
6.35
3.67
1.54
0.70
0.69
Diluted Shares Outstanding
12,713.50
12,713.50
30,401.60
85,558.40
88,546.70
91,828
EBITDA
63,243.00
78,194.00
100,807.00
103,253.00
31,651.00
24,666
Non-Operating Interest Income
267.00
143.00
84.00
1,171.00
1,975.00
4,638

About Novocure

View Profile
Address
No. 4 The Forum
St. Helier Jersey JE2 4UF
United Kingdom
Employees -
Website http://www.novocure.com
Updated 07/08/2019
Novocure Ltd. operates as an oncology company. It enages in developing its propriety technoclogy, Tumor Treating Fields, which uses electric fields tuned to specific frequencies to disrupt cancer cell division, inhibiting tumor growth, and causing affected cancer cells to die. The company was founded by Yoram Palti in 2000 and is headquartered in St.